Skip to main content
Genmab logo

Genmab — Investor Relations & Filings

Ticker · GMAB ISIN · DK0010272202 LEI · 529900MTJPDPE4MHJ122 CO Manufacturing
Open in API
Filings indexed 2,819 across all filing types
Latest filing 2021-07-06 Share Issue/Capital Cha…
Country DK Denmark
Listing CO GMAB

About Genmab

https://www.genmab.com/

Genmab is an international biotechnology company that specializes in the creation, development, and commercialization of differentiated antibody therapeutics. The company focuses on transforming the treatment of cancer and other serious diseases. By utilizing proprietary antibody technology platforms and scientific expertise, Genmab develops a pipeline of innovative medicines. Its activities span from discovery and research through clinical development to deliver novel therapies to patients.

Recent filings

Filing Released Lang Actions
Capital Increase in Genmab as a Result of Employee Warrant Exercise
Share Issue/Capital Change Classification · 100% confidence The document is a formal company announcement from Genmab regarding an increase in share capital resulting from the exercise of employee warrants. It details the number of shares issued, the subscription prices, the impact on total share capital, and the regulatory context under the Danish Capital Markets Act. This fits the definition of a 'Share Issue/Capital Change' (SHA) as it describes a specific event involving the issuance of new shares and a change in the company's capital structure.
2021-07-06 English
Capital Increase in Genmab as a Result of Employee Warrant Exercise
Share Issue/Capital Change Classification · 95% confidence The document is a company announcement regarding a capital increase resulting from the exercise of employee warrants. It details the number of shares issued, the subscription prices, and the resulting change in total share capital. This falls under the category of share issuance or capital changes. While it mentions an attachment, the text itself provides the full details of the transaction, making it a primary announcement of a capital change rather than just a report publication announcement.
2021-07-06 English
6-K
Foreign Filer Report
2021-07-01 English
6-K
Foreign Filer Report
2021-07-01 English
Completion of share buy-back program
Transaction in Own Shares Classification · 100% confidence The document is a formal company announcement from Genmab regarding the completion of a share buy-back program. It details the number of shares repurchased, the total cost, and the impact on treasury shares. This falls directly under the definition of 'Transaction in Own Shares' (POS), which covers reports of a company buying back its own shares.
2021-07-01 English
Completion of share buy-back program
Transaction in Own Shares Classification · 100% confidence The document is a company announcement from Genmab A/S regarding the completion of a share buy-back program. It details the number of shares repurchased, the total value, and references the regulatory framework (MAR/Safe Harbour) under which the transactions were conducted. Since the document reports on the company buying back its own shares, it falls under the 'Transaction in Own Shares' category.
2021-07-01 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.